Xtandi Capsules (Soft Gelatin)
Enzalutamide
40mg
ASTELLAS PHARMA EUROPE B.V.
| Pack size | 112's (28's Wallet x 4) |
|---|---|
| Dispensing mode | POM |
| Source | NETHERLANDS |
| Agent | PHARMATRADE |
| Retail Price | 19511.50 AED |
Indications
Xtandi Capsules (Soft Gelatin) is used for:
Enzalutamide is indicated for the treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel.
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Enzalutamide :
Mechanism of Action
Enzalutamide is a competitive androgen receptor inhibitor that effects multiple stages of the signalling pathway. It is able to inhibit androgen binding to its receptor, androgen receptor nuclear translocation, and subsequent interaction with DNA. As a result, proliferation of prostate cancer cells decreases which ultimately leads to apoptosis and decreased tumour volume.
Note
Xtandi 40mg Capsules (Soft Gelatin) manufactured by ASTELLAS PHARMA EUROPE B.V.. Its generic name is Enzalutamide. Xtandi is availble in United Arab Emirates.
Farmaco UAE drug index information on Xtandi Capsules (Soft Gelatin) is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.